Future-Proofing Biopharma Launches Requires Personalizing the Customer Experience
As the U.S. economy reopens, engagement with healthcare providers and pharma manufacturers will vary significantly from person to person depending on their comfort level. This article provides insight on how engagement could affect product launches.
Adapting Biopharma Launches in the COVID-19 Landscape
Judith Kulich and Ben Hohn pose the high priority questions that those teams opting to move forward with a launch, or to move forward after a delay, in the face of the COVID-19 pandemic.
Is the Tail Wagging the Dog in Drug Market Entry?
Three product launch trends driven by emerging biopharma.
2 Commerce Drive Cranbury, NJ 08512